Longevity Biotech


Longevity Biotech is developing a new class of therapeutic candidates called Hybridtides. Their focus is on delivering clinically transformative products that tackle the most challenging aspects of medicine today.

Industries

Employees

1-10

Links


Org chart

Scott Shandler
Founder & CEO
Collapse
Samuel Gellman
Co-founder And CSO

Board & advisors



Offices